Business Context and Reporting Period
This Form 8-K was filed by CTS Corporation on March 16, 2016, reporting a material event that occurred on March 11, 2016. The filing details the completion of an acquisition in the medical and defense technology sectors.
Key Financial Metrics
The filing discloses a specific transaction value but does not provide comprehensive financial statements, revenue, profit, cash flow, or debt metrics for the reporting period.
- Acquisition Cost: $73 million in cash.
- Target Company: CTG Advanced Materials, LLC ("CTG-AM").
- Seller: BW Piezo Holdings, LLC (managed by Blue Wolf Capital Partners LLC).
Material Changes
The primary material change is the expansion of CTS Corporation's portfolio through the acquisition of CTG-AM. CTG-AM is described as the market-leading designer and manufacturer of single crystal piezoelectric materials. These materials enable high-definition ultrasound imaging, intravascular ultrasound technology, wireless pacemakers, implantable hearing aids, and defense technologies.
Guidance, Outlook, and Risks
The filing does not contain updated financial guidance, management commentary on future outlook, or specific risk factors related to the transaction beyond the standard disclosure of the acquisition itself. The transaction was publicly announced via a press release on March 14, 2016, which is attached as Exhibit 99.1.
Investor Verification Checklist
- Verify the impact of the $73 million cash outflow on CTS Corporation's current liquidity and debt covenants.
- Review the attached press release (Exhibit 99.1) for additional details on integration plans or expected synergies.
- Confirm the valuation multiples paid for CTG-AM relative to its market position in single crystal piezoelectric materials.
- Monitor future filings for any goodwill impairment or integration costs associated with the acquisition.